Lendway Announces Acquisition of Bloomia - Seite 2
"We are excited to announce Bloomia's integration into the Lendway family," said Bloomia CEO, Werner Jansen. "This marks an exciting chapter in our journey, one that promises opportunity and potential for immense growth. Our passion for cultivating world-renowned tulips remains steadfast as we embark on this new capital partnership. While our heritage lies in the Netherlands, our global perspective drives us to embrace this new chapter wholeheartedly. We are confident that together with Lendway, we will reach new heights and continue to flourish in the floral industry."
"As a Lendway stockholder, I wholeheartedly endorse and applaud the completion of this transaction," said Nick Swenson, a member of the Lendway Board of Directors. "This timely and strategic move not only reflects the Board's commitment to delivering exceptional value to our shareholders, but also positions the Company for long-term growth. I am confident that this investment reinforces Lendway's foundation, propelling its evolution into a dynamic specialty ag and finance company."
CapFit served as Lendway's financial adviser and JB Law and Faegre Drinker served as legal advisers to Lendway.
About Lendway
Lendway, Inc. (Nasdaq:LDWY) is a specialty ag and finance company focused on making and managing its ag investments in the U.S. and internationally. The Company fully owns and operates
FarmlandCredit.com, a non-bank lending business that seeks to purchase existing loans and/or originate and fund new loans domestically. The Company is also the majority owner of Bloomia.com, one of
the largest producers of fresh cut tulips in the United States. For additional information, contact (800) 874-4648, or visit our website at www.lendway.com. Investor inquiries can be submitted to info@lendway.com.
Lesen Sie auch
Cautionary Statement for the Purpose of Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995
Statements in this press release that are not statements of historical or current facts are considered forward-looking statements within the meaning of the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995, as amended. The words "anticipate," "believe," "continue," "expect," "keep," "plan," "positions," "potential," "promises," "remain," "seek," "will" and
similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these or any forward-looking statements, which speak only as of the date of this press
release. Statements made in this press release regarding, for instance, potential value for stockholders and growth in the Lendway generally and Bloomia specifically, are forward-looking
statements. These forward-looking statements are based on current information, which we have assessed and which by its nature is dynamic and subject to rapid and even abrupt changes. As such,
actual results may differ materially from the results or performance expressed or implied by such forward-looking statements. Forward-looking statements involve known and unknown risks,
uncertainties and other factors, including our ability to maintain and integrate the acquired business, changes competition or price pressure resulting from public announcement of the acquisition,
changes in demand and customer requirements for our products, delays or interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our
control that may negatively impact our business or the supply chains in which we participate, risks associated with international operations, including import regulations, and those set forth in
our Annual Report on Form 10-K for the year ended December 31, 2022 and additional risks, identified in our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K filed with the SEC.
Such forward-looking statements should be read in conjunction with Lendway's filings with the SEC. Lendway assumes no responsibility to update the forward-looking statements contained in this press
release or the reasons why actual results would differ from those anticipated in any such forward-looking statement, other than as required by law.